Sleep and the Endocrine System

Critical Care Clinics

Volumn 31, Issue 3, 2015, Pages 403-418

  Morgan, Dionne ^a   Tsai, Sheila C ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Circadian rhythms; Critical care; Critical illness; Endocrine abnormalities; Hormonal regulation; Sleep apnea; Sleep deprivation; Sleep disorders

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CORTICOTROPIN; ESTROGEN; FOLLITROPIN; GHRELIN; GLUCOSE; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEPTIN; LUTEINIZING HORMONE; MELATONIN; PROGESTERONE; PROLACTIN; RENIN; TESTOSTERONE; THYROTROPIN;

ACROMEGALY; APPETITE; CARCINOGENICITY; CIRCADIAN RHYTHM; CRITICAL ILLNESS; ENDOCRINE DISEASE; GLUCOSE METABOLISM; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYPERSOMNIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; INSULIN METABOLISM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP WAKING CYCLE; ENDOCRINE SYSTEM; INTENSIVE CARE; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP;

CIRCADIAN RHYTHM; CRITICAL CARE; ENDOCRINE SYSTEM; ENDOCRINE SYSTEM DISEASES; HUMANS; SLEEP;

EID: 84937562793     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2015.03.004     Document Type: Review

References (97)

1. Van Cauter E., Blackman J.D., Roland D., et al. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 1991, 88:934-942.
2. Axelsson J., Ingre M., Akerstedt T., et al. Effects of acutely displaced sleep on testosterone. J Clin Endocrinol Metab 2005, 90:4530-4535.
3. Luboshitzky R., Herer P., Levi M., et al. Relationship between rapid eye movement sleep and testosterone secretion in normal men. J Androl 1999, 20:731-737.
4. Sinha M.K., Ohannesion J.P., Heiman M.L., et al. Nocturnal rise of leptin in lean, obese, and non insulin-dependent diabetes mellitus subjects. J Clin Invest 1996, 97:1344-1347.
5. Simon C., Grofier C., Schlienger J.L., et al. Circadian and ultradian variations of leptin in normal man under continuous enteral nutrition: relationship to sleep and body temperature. J Clin Endocrinol Metab 1998, 83:1893-1899.
6. Saad M.F., Riad-Gabriel M.G., Khan A., et al. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J Clin Endocrinol Metab 1998, 83:453-459.
7. Dzaja A., Dalal M.A., Himmerich H., et al. Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am J Physiol Endocrinol Metab 2004, 286:E963-E967.
8. Weikel J.C., Wichniak A., Ising M., et al. Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab 2003, 284:E407-E415.
9. Kern W., Offenheuser S., Born J., et al. Entrainment of ultradian oscillations in the secretion of insulin and glucagons to the nonrapid eye movement/rapid eye movement sleep rhythm in humans. J Clin Endocrinol Metab 1996, 81:1541-1547.
10. Levy I., Recasens A., Casamitjana R., et al. Nocturnal insulin and C-peptide rhythms in normal subjects. Diabetes Care 1987, 10:148-151.
11. Boyle P.J., Scott J.C., Krentz A.J., et al. Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest 1994, 93:529-535.
12. Van Cauter E., Polonsky K.S., Scheen A.J. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997, 18:716-738.
13. Colao A., Ferone D., Marzullo P., et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004, 25:102-152.
14. Hochban W., Ehlenz K., Conradt R., et al. Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur Respir J 1999, 14:196-202.
15. Roxburgh F., Collis A.J. Notes on a case of acromegaly. Br Med J 1896, 2:63-65.
16. Grunstein R.R., Ho K.Y., Sullivan C.E. Sleep apnea in acromegaly. Ann Intern Med 1991, 115:527-532.
17. Grunstein R.R., Ho K.Y., Berthon-Jones M., et al. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 1994, 150:496-502.
18. Rosenow F., Reuter S., Deuss U., et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf) 1996, 45:563-569.
19. Mickelson S.A., Rosenthal L.D., Rock J.P., et al. Obstructive sleep apnea syndrome and acromegaly. Otolaryngol Head Neck Surg 1994, 111:25-30.
20. Grunstein R.R., Ho K.K.Y., Sullivan C.E. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med 1994, 121:478-483.
21. Herrmann B.L., Wessendorf T.E., Ajaj W., et al. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 2004, 151:309-315.
22. Pekkarinen T., Partinen M., Pelkonen R., et al. Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clin Endocrinol (Oxf) 1987, 27:649-654.
23. Pelttari L., Polo O., Rauhala E., et al. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin Endocrinol (Oxf) 1995, 43:175-182.
24. Pelttari L., Rauhala E., Polo O., et al. Upper airway obstruction in hypothyroidism. J Intern Med 1994, 236:177-181.
25. Jha A., Sharma S.K., Tandon N., et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep Med 2006, 7:55-61.
26. Grunstein R.R., Sullivan C.E. Sleep apnea and hypothyroidism: mechanisms and management. Am J Med 1988, 85:775-779.
27. Krishnan P.V., Vadivu A.S., Alappatt A., et al. Prevalence of sleep abnormalities and their association among hypothyroid patients in an Indian population. Sleep Med 2012, 13:1232-1237.
28. Resta O., Carratù P., Carpagnano G.E., et al. Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS). J Endocrinol Invest 2005, 28:893-898.
29. Shinno H., Inami Y., Inagaki T., et al. Successful treatment with levothyroxine for idiopathic hypersomnia patients with subclinical hypothyroidism. Gen Hosp Psychiatry 2009, 31:190-193.
30. Lu C.L., Lee Y.C., Tsai S.J., et al. Psychiatric disturbances associated with hyperthyroidism: an analysis report of 30 cases. Zhonghua Yi Xue Za Zhi (Taipei) 1995, 56:393-398.
31. Sridhar G.R., Putcha V., Lakshmi G. Sleep in thyrotoxicosis. Indian J Endocrinol Metab 2011, 15:23-26.
32. Pereira J.C., Pradella-Hallinan M., Pessoa H.L. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics 2010, 65:547-554.
33. Aulinas A., Webb S.M. Health-related quality of life in primary and secondary adrenal insufficiency. Expert Rev Pharmacoecon Outcomes Res 2014, 14:873-888.
34. Seelig E., Keller U., Klarhöfer M., et al. Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study. PLoS One 2013, 8:e61780.
35. Xia L., Chen G.H., Li Z.H., et al. Alterations in hypothalamus-pituitary-adrenal/thyroid axes and gonadotropin-releasing hormone in the patients with primary insomnia: a clinical research. PLoS One 2013, 8:e71065.
36. Shipley J.E., Schteingart D.E., Tandon R., et al. Sleep architecture and sleep apnea in patients with Cushing's disease. Sleep 1992, 15:514-518.
37. Berger G., Hardak E., Shaham B., et al. Preliminary prospective explanatory observation on the impact of 3-month steroid therapy on the objective measures of sleep-disordered breathing. Sleep Breath 2012, 16:549-553.
38. Kenna H.A., Poon A.W., de los Angeles C.P., et al. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci 2011, 65:549-560.
39. Miller C.M., Rindflesch T.C., Fiszman M., et al. A closed literature-based discovery technique finds a mechanistic link between hypogonadism and diminished sleep quality in aging men. Sleep 2012, 35:279-285.
40. Shi Z., Araujo A.B., Martin S., et al. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metab 2013, 98:3289-3297.
41. Resta O., Foschino Barbaro M.P., Bonfitto P., et al. Low sleep quality and daytime sleepiness in obese patients without obstructive sleep apnoea syndrome. J Intern Med 2003, 253:536-543.
42. Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab 2011, 96:2341-2353.
43. Hanafy H.M. Testosterone therapy and obstructive sleep apnea: is there a real connection?. J Sex Med 2007, 4:1241-1246.
44. Hoyos C.M., Killick R., Yee B.J., et al. Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial. Clin Endocrinol 2012, 77:599-607.
45. Venancio D.P., Tufik S., Garbuio S.A., et al. Effects of anabolic androgenic steroids on sleep patterns of individuals practicing resistance exercise. Eur J Appl Physiol 2008, 102:555-560.
46. Young T., Finn L., Austin D., et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003, 167:1181-1185.
47. Sarti C.D., Chiantera A., Graziottin A., et al. Hormone therapy and sleep quality in women around menopause. Menopause 2005, 12:545-551.
48. Cistulli P.A., Barnes D.J., Grunstein R.R., et al. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994, 49:699-702.
49. Burgess H.J., Revell V.L., Molina T.A., et al. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab 2010, 95:3325-3331.
50. Sack R.L., Brandes R.W., Kendall A.R., et al. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000, 343:1070-1077.
51. Sack R.L., Hughes R.J., Edgar D.M., et al. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms?. Sleep 1997, 20:908-915.
52. Sharkey K.M., Fogg L.F., Eastman C.I. Effects of melatonin administration on daytime sleep after simulated night shift work. J Sleep Res 2001, 10:181-192.
53. Aeschbach D., Lockyer B.J., Dijk D.J., et al. Use of transdermal melatonin delivery to improve sleep maintenance during daytime. Clin Pharmacol Ther 2009, 86:378-382.
54. Wyatt J.K., Dijk D.J., Ritz-De Cecco A., et al. Sleep facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 2006, 29:609-618.
55. Zhdanova I.V., Wurtman R.J. Efficacy of melatonin as a sleep-promoting agent. J Biol Rhythms 1997, 12:644-650.
56. Leproult R., Copinschi G., Buxton O., et al. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997, 20:865-870.
57. Vgontzas A.N., Mastorakos G., Bixler E.O., et al. Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications. Clin Endocrinol 1999, 51:205-215.
58. Guyon A., Balbo M., Morselli L.L., et al. Adverse effects of two nights of sleep restriction on the hypothalamic-pituitary-adrenal axis in healthy men. J Clin Endocrinol Metab 2014, 99:2861-2868.
59. Reutrakul S., Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci 2014, 1311:151-173.
60. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
61. Buxton O.M., Pavlova M., Reid E.W., et al. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes 2010, 59:2126-2133.
62. Knutson K.L., Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008, 1129:287-304.
63. Mullington J.M., Chan J.L., Van Dongen H.P., et al. Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men. J Neuroendocrinol 2003, 15:851-854.
64. Spiegel K., Leproult R., L'Hermite-Baleriaux M., et al. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004, 89:5762-5771.
65. Taheri S., Lin L., Austin D., et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004, 1(3):e62.
66. Markwald R.R., Melanson E.L., Smith M.R., et al. Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc Natl Acad Sci U S A 2013, 110(4):5695-5700.
67. Vgontzas A., Bixler E.O., Lin H.M., et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 2001, 86(8):3787-3794.
68. Vallières A., Ceklic T., Bastein C.H., et al. A preliminary evaluation of the physiological mechanisms of action for sleep restriction therapy. Sleep Disord 2013, 2013:726372.
69. Tasali E., Leproult R., Ehrmann D.A., et al. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 2008, 105:1044-1049.
70. Vgontzas A.N., Liao D., Pejovic S., et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep 2010, 33:1159-1164.
71. Vgontzas A.N., Liao D., Pejovic S., et al. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care 2009, 32:1980-1985.
72. Attal P., Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab 2010, 95:483-495.
73. Yee B., Liu P., Phillips C., et al. Neuroendocrine changes in sleep apnea. Curr Opin Pulm Med 2004, 10:475-481.
74. Ip M.S., Lam B., Ng M.M., et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670-676.
75. Punjabi N.M., Sorkin J.D., Katzel L.I., et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165:677-682.
76. Svatikova A., Wolk R., Gami A.S., et al. Interactions between obstructive sleep apnea and the metabolic syndrome. Curr Diab Rep 2005, 5:53-58.
77. Coughlin S.R., Mawdsley L., Mugarza J.A., et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004, 25:735-741.
78. McMenamin T. A time to work: recent trends in shift work and flexible schedules. Mon Labor Rev 2007, 3-15.
79. Shibui K., Uchiyama M., Kim K., et al. Melatonin, cortisol and thyroid-stimulating hormone rhythms are delayed in patients with delayed sleep phase syndrome. Sleep Biol Rhythms 2003, 1:209-214.
80. Scheer F., Hilton M., Mantzoros C., et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 2009, 106:4453-4458.
81. Gonnissen H., Rutters F., Mazuy C., et al. Effect of a phase advance and phase delay of the 24-h cycle on energy metabolism, appetite, and related hormones. Am J Clin Nutr 2012, 96:689-697.
82. Pan A., Schernhammer E.S., Sun Q., et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med 2011, 8(12):e1001141.
83. Monk T.H., Buysse D.J. Exposure to shift work as a risk factor for diabetes. J Biol Rhythms 2013, 28:356-359.
84. Leproult R., Holmbäck U., Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 2014, 63:1860-1869.
85. Davis S., Mirick D.K. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 2006, 17:539-545.
86. Tamarkin L., Cohen M., Roselle D., et al. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 1981, 41:4432-4436.
87. Mocchegiani E., Perissin L., Santarelli L., et al. Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2. Int J Immunopharmacol 1999, 21:27-46.
88. Maurovich-Horvat E., Keckeis M., Zuzana Lattov Z., et al. Hypothalamo-pituitary-adrenal axis, glucose metabolism and TNF-alpha in narcolepsy. J Sleep Res 2014, 23:425-431.
89. Beitinger P.A., Fulda S., Dalal M.A., et al. Glucose tolerance in patients with narcolepsy. Sleep 2012, 35:231-236.
90. Engel A., Helfrich J., Manderscheid N., et al. Investigation of insulin resistance in narcoleptic patients: dependent or independent of body mass index?. Neuropsychiatr Dis Treat 2011, 7:351-356.
91. Cooper A.B., Thornley K.S., Young G.B., et al. Sleep in critically ill patients requiring mechanical ventilation. Chest 2000, 117:809-818.
92. Freedman N.S., Gazendam J., Levan L., et al. Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit. Am J Respir Crit Care Med 2001, 163:451-457.
93. Shilo L., Dagan Y., Smorjik Y., et al. Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern. Am J Med Sci 1999, 317:278-281.
94. Perras B., Meier M., Dodt C. Light and darkness fail to regulate melatonin release in critically ill humans. Intensive Care Med 2007, 33:1954-1958.
95. Mundigler G., Delle-Karth G., Koreny M., et al. Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit Care Med 2002, 30:536-540.
96. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 2000, 143:1-13.
97. Vanhorebeek I., Langouche L., Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006, 1:20-31.